Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
Weyer C, Bogardus C, Mott DM, Pratley RE. Weyer C, et al. J Clin Invest. 1999 Sep;104(6):787-94. doi: 10.1172/JCI7231. J Clin Invest. 1999. PMID: 10491414 Free PMC article.
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.
Ratner RE, Dickey R, Fineman M, Maggs DG, Shen L, Strobel SA, Weyer C, Kolterman OG. Ratner RE, et al. Among authors: weyer c. Diabet Med. 2004 Nov;21(11):1204-12. doi: 10.1111/j.1464-5491.2004.01319.x. Diabet Med. 2004. PMID: 15498087 Clinical Trial.
Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.
Weyer C, Maggs DG, Young AA, Kolterman OG. Weyer C, et al. Curr Pharm Des. 2001 Sep;7(14):1353-73. doi: 10.2174/1381612013397357. Curr Pharm Des. 2001. PMID: 11472273 Review.
The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.
Pratley RE, Weyer C. Pratley RE, et al. Among authors: weyer c. Diabetologia. 2001 Aug;44(8):929-45. doi: 10.1007/s001250100580. Diabetologia. 2001. PMID: 11484070 Review.
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Weyer C, et al. J Clin Endocrinol Metab. 2001 May;86(5):1930-5. doi: 10.1210/jcem.86.5.7463. J Clin Endocrinol Metab. 2001. PMID: 11344187
Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight.
Weyer C, Hanson K, Bogardus C, Pratley RE. Weyer C, et al. Diabetologia. 2000 Jan;43(1):36-46. doi: 10.1007/s001250050005. Diabetologia. 2000. PMID: 10663214
Measurement of insulin sensitivity: influence of potassium supply during euglycaemic glucose clamps in healthy volunteers.
Rave K, Heise T, Weyer C, Sawicki P, Heinemann L. Rave K, et al. Among authors: weyer c. Exp Clin Endocrinol Diabetes. 1999;107(5):313-7. doi: 10.1055/s-0029-1212118. Exp Clin Endocrinol Diabetes. 1999. PMID: 10482044 Clinical Trial.
Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304.
Heinemann L, Sinha K, Weyer C, Loftager M, Hirschberger S, Heise T. Heinemann L, et al. Among authors: weyer c. Diabet Med. 1999 Apr;16(4):332-8. doi: 10.1046/j.1464-5491.1999.00081.x. Diabet Med. 1999. PMID: 10220208 Clinical Trial.
Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Kimmerle R, Heinemann L, Heise T, Bender R, Weyer C, Hirschberger S, Berger M. Kimmerle R, et al. Among authors: weyer c. Menopause. 1999 Spring;6(1):36-42. Menopause. 1999. PMID: 10100178 Clinical Trial.
Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
Heinemann L, Weyer C, Rauhaus M, Heinrichs S, Heise T. Heinemann L, et al. Among authors: weyer c. Diabetes Care. 1998 Nov;21(11):1910-4. doi: 10.2337/diacare.21.11.1910. Diabetes Care. 1998. PMID: 9802742 Clinical Trial.
123 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page